Two Sigma Investments’s Cellectis CLLS Stock Holding History
Bought
Maintained
Sold
Other funds holding CLLS
LFCM
BGI
Two Sigma Investments's CLLS Position: Q1 2025 in Review
Two Sigma Investments sold out of Cellectis (CLLS) in Q1 2025, closing a stake of 27,322 shares — an estimated $49.2K sold.
Two Sigma Investments first reported a position in CLLS in Q4 2018 and held it in 13 quarters. The position peaked at $935K in Q1 2021. 27 funds tracked by Wall St. Rank hold CLLS as of Q1 2025.
- Two Sigma Investments reported no remaining Cellectis position as of Q1 2025 after selling out during the quarter.
- Two Sigma Investments sold 27,322 Cellectis shares in Q1 2025, an estimated $49.2K.
- Two Sigma Investments first reported a position in Cellectis in Q4 2018 and held it in 13 quarters.
- Two Sigma Investments's Cellectis position peaked at $935K in Q1 2021.
- 27 funds tracked by Wall St. Rank held Cellectis as of Q1 2025.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.